The Reply - 27/09/18
Doi : 10.1016/j.amjmed.2018.05.024
Muthiah Vaduganathan, MD MPH a, Manan Pareek, MD PhD a, b, Arman Qamar, MD a, Ambarish Pandey, MD c, Michael H Olsen, MD PhD DMSc b, d, Deepak L Bhatt, MD MPH a, ⁎ 
a Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA, USA
b Cardiovascular and Metabolic Preventive Clinic, Department of Endocrinology, Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, Denmark
c Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA
d Cardiology Section, Department of Internal Medicine, Holbaek Hospital, Denmark
⁎Request for reprints should be addressed to: Deepak L. Bhatt, MD, MPH; Brigham and Women's Hospital Heart & Vascular Center, 75 Francis St, Boston, MA 02115; Tel 857-307-1992; Fax 857-307-1955Brigham and Women's Hospital Heart & Vascular Center75 Francis St, BostonMA02115
Le texte complet de cet article est disponible en PDF.
| Disclosures: Drs. Muthiah Vaduganathan and Arman Qamar are supported by the NHLBI T32 postdoctoral training grant (T32HL007604). Dr. Manan Pareek discloses the following relationships – Advisory Board: AstraZeneca; Speaker Honorarium: AstraZeneca. Dr. Michael H. Olsen discloses that he has received a part-time clinical research grant from the Novo Nordisk Foundation. Dr. Deepak L. Bhatt discloses the following relationships - Advisory Board: Cardax, Elsevier Practice Update Cardiology, Medscape Cardiology, Regado Biosciences; Board of Directors: Boston VA Research Institute, Society of Cardiovascular Patient Care; Chair: American Heart Association Quality Oversight Committee; Data Monitoring Committees: Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute), Cleveland Clinic, Duke Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, Population Health Research Institute; Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org; Vice-Chair, ACC Accreditation Committee), Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; clinical trial steering committee), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), HMP Global (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Guest Editor; Associate Editor), Population Health Research Institute (clinical trial steering committee), Slack Publications (Chief Medical Editor, Cardiology Today's Intervention), Society of Cardiovascular Patient Care (Secretary/Treasurer), WebMD (CME steering committees); Other: Clinical Cardiology (Deputy Editor), NCDR-ACTION Registry Steering Committee (Chair), VA CART Research and Publications Committee (Chair); Research Funding: Abbott, Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Idorsia, Ironwood, Ischemix, Lilly, Medtronic, PhaseBio, Pfizer, Regeneron, Roche, Sanofi Aventis, The Medicines Company; Royalties: Elsevier (Editor, Cardiovascular Intervention: A Companion to Braunwald's Heart Disease); Site Co-Investigator: Biotronik, Boston Scientific, St. Jude Medical (now Abbott), Svelte; Trustee: American College of Cardiology; Unfunded Research: FlowCo, Merck, PLx Pharma, Takeda. The other author reports no relationships relevant to the contents of this paper to disclose. |
|
| Reference Letter to the Editor: Leggio M, Caldarone E, Lombardi M, D'Emidio S, Severi P, Bendini MG, Mazza A, Fusco A. The Role of Physical Activity in the New 2017 ACC/AHA Blood Pressure Guidelines. Am J Med. 2018 (in press). |
© 2018
Publié par Elsevier Masson SAS.
Vol 131 - N° 9
P. e389-e390 - septembre 2018 Retour au numéro
Article précédent
- The Role of Physical Activity in the New 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines
- Massimo Leggio, Elisa Caldarone, Mario Lombardi, Stefania D'Emidio, Paolo Severi, Maria Grazia Bendini, Andrea Mazza, Augusto Fusco
- Ten Most Important Things to Know About Caring for Transgender Patients
- Jin Jun Luo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?